Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

November 10, 2023 updated by: Wang Jiaqiang, Henan Cancer Hospital

A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

A total of 200 patients with malignant tumors will be enrolled in Henan Cancer Hospital. This study is a single-center prospective real-world observational study, and all eligible patients are planned to be enrolled. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Wang Jiaqiang, Dr
  • Phone Number: 13592413731
  • Email: wjqwtj@126.com

Study Locations

  • China
    • Henan
      • Zhengzhou, Henan, China, 450008
        • Recruiting
        • Department of Bone and Soft Tissue ,Henan Cancer Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with malignant tumors diagnosed by pathology receiving inpatient treatment in Henan Cancer Hospital.

Description

Inclusion Criteria:

  1. Men and women of all ages are welcome.
  2. Pathological diagnosis of malignant tumor in our hospital.
  3. Received at least one hospitalization at this hospital.
  4. The expected survival time is greater than 1 year.

Exclusion Criteria:

1.There was no pathological report of malignancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital Anxiety Depression Scale
Time Frame: Confirmed in 1 day
Confirmed in 1 day
Confirmed in 1 day
Hospital Anxiety Depression Scale
Time Frame: End of the treatment
End of the treatment
End of the treatment
Hospital Anxiety Depression Scale
Time Frame: The treatment ended 3 months later
The treatment ended 3 months later
The treatment ended 3 months later
Hospital Anxiety Depression Scale
Time Frame: The treatment ended 6 months later
The treatment ended 6 months later
The treatment ended 6 months later
Hospital Anxiety Depression Scale
Time Frame: The treatment ended one year later
The treatment ended one year later
The treatment ended one year later
Hospital Anxiety Depression Scale
Time Frame: The treatment ended 2 years ago
The treatment ended 2 years ago
The treatment ended 2 years ago

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Henan Cancer Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2023

Primary Completion (Estimated)

November 30, 2032

Study Completion (Estimated)

November 30, 2032

Study Registration Dates

First Submitted

October 24, 2022

First Submitted That Met QC Criteria

October 24, 2022

First Posted (Actual)

October 27, 2022

Study Record Updates

Last Update Posted (Actual)

November 13, 2023

Last Update Submitted That Met QC Criteria

November 10, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ZZUSC-16

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Hospital Anxiety and Depression Scale

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe